Deep Track Capital, LP Fulcrum Therapeutics, Inc. Transaction History

Deep Track Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$5.01 - $8.35 $661,841 - $1.1 Million	-132,104 Reduced 14.67%	768,607 $5.6 Million
Q3 2022 Nov 14, 2022	SELL	$4.92 - $9.1 $488,501 - $903,529	-99,289 Reduced 9.93%	900,711 $7.29 Million
Q2 2022 Aug 12, 2022	BUY	$4.2 - $24.0 $1.47 Million - $8.4 Million	350,000 Added 53.85%	1,000,000 $4.9 Million
Q1 2022 May 16, 2022	SELL	$9.96 - $23.65 $996,000 - $2.37 Million	-100,000 Reduced 13.33%	650,000 $15.4 Million
Q4 2021 Feb 14, 2022	BUY	$14.0 - $28.44 $10.5 Million - $21.3 Million	750,000 New	750,000 $13.3 Million

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $237M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.